Roden DM - Search Results

1

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith RF, Oates JA, Woosley RL. Roden DM, et al. Am J Cardiol. 1980 Sep;46(3):463-8. doi: 10.1016/0002-9149(80)90016-8. Am J Cardiol. 1980. PMID: 6158263 Clinical Trial.

2

Importance of metabolites in antiarrhythmic therapy.

Woosley RL, Roden DM. Woosley RL, et al. Among authors: roden dm. Am J Cardiol. 1983 Sep 22;52(6):3C-7C. doi: 10.1016/0002-9149(83)90625-2. Am J Cardiol. 1983. PMID: 6194679

3

Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog.

Dawson AK, Roden DM, Duff HJ, Woosley RL, Smith RF. Dawson AK, et al. Among authors: roden dm. Am J Cardiol. 1984 Sep 1;54(6):654-8. doi: 10.1016/0002-9149(84)90267-4. Am J Cardiol. 1984. PMID: 6475789

4

Electrophysiologic actions of high plasma concentrations of propranolol in human subjects.

Duff HJ, Roden DM, Brorson L, Wood AJ, Dawson AK, Primm RK, Oates JA, Smith RF, Woosley RL. Duff HJ, et al. Among authors: roden dm. J Am Coll Cardiol. 1983 Dec;2(6):1134-40. doi: 10.1016/s0735-1097(83)80340-4. J Am Coll Cardiol. 1983. PMID: 6630784 Free article.

5

Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.

Funck-Brentano C, Light RT, Lineberry MD, Wright GM, Roden DM, Woosley RL. Funck-Brentano C, et al. Among authors: roden dm. J Cardiovasc Pharmacol. 1989 Sep;14(3):364-73. doi: 10.1097/00005344-198909000-00003. J Cardiovasc Pharmacol. 1989. PMID: 2476614

6

QT prolongation and arrhythmia suppression.

Roden DM, Woosley RL. Roden DM, et al. Am Heart J. 1985 Feb;109(2):411-5. doi: 10.1016/0002-8703(85)90627-1. Am Heart J. 1985. PMID: 2578242

7

Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.

Roden DM, Lee JT, Woosley RL, Echt DS. Roden DM, et al. Circulation. 1989 Nov;80(5):1247-58. doi: 10.1161/01.cir.80.5.1247. Circulation. 1989. PMID: 2805262

8

Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.

Woosley RL, Echt DS, Roden DM. Woosley RL, et al. Among authors: roden dm. Am J Cardiol. 1986 Jan 31;57(3):25B-33B. doi: 10.1016/0002-9149(86)90995-1. Am J Cardiol. 1986. PMID: 3080860 Review.

9

Disposition kinetics of encainide and metabolites.

Roden DM, Wood AJ, Wilkinson GR, Woosley RL. Roden DM, et al. Am J Cardiol. 1986 Aug 29;58(5):4C-9C. doi: 10.1016/0002-9149(86)90097-4. Am J Cardiol. 1986. PMID: 3092618 Review.

10

Tocainide plus quinidine for treatment of ventricular arrhythmias.

Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM. Barbey JT, et al. Among authors: roden dm. Am J Cardiol. 1988 Mar 1;61(8):570-3. doi: 10.1016/0002-9149(88)90766-7. Am J Cardiol. 1988. PMID: 3125737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

806 results

Search Page